Key facts
- It has raised $990K.
- Notable investors include B&Y Venture Partners, dmg ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NUL
- ·The full record, as it builds
Funding rounds
No funding rounds for NUL are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NUL
Provider of alcohol reduction treatment services intended to eliminate alcohol consumption. The company offers services such as prescription medication programme, treatment plan, daily medication, repeat prescription support, monthly clinician check-in, weekly coach-led community support groups, and more, helping patients with prescription treatment and therapy for those seeking additional guidance.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 15
- Website
- choosenul.com/
- Ownership
- Privately Held (backing)
NUL doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NUL shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NUL in its N-PORT filings yet. We sweep new filings monthly.